WHO Report: Urgent Global Action Needed on Cancer

Global cancer cases claim more than 26,000 lives daily, making the disease the second leading cause of death worldwide after cardiovascular disease, according to the WHO Global Status Report on Cancer 2026. Developed jointly with the International Agency for Research on Cancer and issued in July 2026, the report documents widening global inequities in access to prevention, diagnosis, and treatment, alongside a projection that annual new cancer cases will reach 35 million by 2050.

Global Disparities in Survival Rates and Healthcare Access

Survival outcomes for cancer patients vary drastically depending on geography and income, according to the WHO report. While 87% of women diagnosed with breast cancer survive for five years in high-income countries, that figure drops to 42% in low-income countries. Furthermore, fewer than one in three countries currently include cancer care in their universal health coverage packages.

“Whether a person survives cancer should never depend on where they were born or what they earn,” said WHO Director-General Tedros Adhanom Ghebreyesus, MSc, PhD. He noted that these documented inequities are consequences of choices that can be reversed through unified action.

Regional Burden and Leading Cancer Types

The global cancer burden is distributed unevenly across continents. In 2024, Asia accounted for 50.7% of all cancer cases and 56.5% of deaths due to its large population. Europe contributed 21% of global cases and 20% of deaths despite housing only about 9% of the world’s population. Conversely, many African nations and parts of Asia experience lower incidence rates alongside disproportionately high mortality.

By cancer type, lung cancer remains the leading cause of death globally. Among men, lung, prostate, and colorectal cancers are the most common. Among women, breast, lung, and colorectal cancers comprise a substantial share of the overall disease burden.

Progress in Prevention Policies and Policy Gaps

Despite persistent challenges, countries have made measurable gains in policy implementation. Tobacco use has declined by 27% since 2010, driving reductions in lung cancer cases and deaths in specific regions. Additionally, infection-related cancers are decreasing due to expanded vaccination coverage, improved water and sanitation, and better infection control practices.

Political commitment has also grown. According to the report, 82% of countries now have national cancer control plans, marking an increase from 50% in 2010. High-income nations report that early detection programs catch most breast cancer cases, with 74% of women screened for cervical cancer. Scientific innovation has similarly accelerated, with registered clinical trials expanding at an annual rate of 7.3% between 2005 and 2021.

Yet, gaps in therapeutics remain stark. The availability of 20 priority cancer therapeutics ranges from just 9% to 54% in low- and lower-middle-income countries, compared to 68% to 94% in high-income nations, according to the IARC and WHO data.

Socioeconomic Toll on Patients and Families

Beyond clinical outcomes, a cancer diagnosis exacts a heavy socioeconomic toll. The report indicates that at least 45% of individuals with cancer and their families experience financial hardship. More than half report mental health challenges, while nearly all caregivers report strain, including unpaid labor and social isolation.

“Cancer is not just a medical diagnosis—it profoundly, indefinitely affects every aspect of a person’s life, and their family’s as well,” said Clarissa Schilstra, a survivor of childhood cancer and a lead of WHO’s survey, urging policymakers to engage directly with individuals possessing lived experience.

Moving Toward a People-Centered Cancer Control Agenda

To address these systemic challenges, the WHO report outlines seven key recommendations and three strategic shifts centered around better capabilities, better protections, and better value. These measures call for integrating cancer care into universal health coverage, strengthening social protections, and aligning research with public health needs.

Global estimates and data from the report are available through the Global Cancer Observatory managed by the IARC. Experts emphasize that sustained, strategic investments and a commitment to equity will determine whether future generations face a mitigated or escalating cancer burden.

Frequently Asked Questions

What is the second leading cause of death globally?

Cancer is the second leading cause of death globally after cardiovascular disease, claiming more than 26,000 lives daily according to the WHO Global Status Report on Cancer 2026.

How do breast cancer survival rates differ by country income level?

In high-income countries, 87% of women with breast cancer survive for five years post-diagnosis, whereas only 42% survive for five years in low-income countries, as reported by the WHO and IARC.

What percentage of cancer cases are linked to preventable risk factors?

Nearly 4 in 10 cancer cases globally are linked to preventable risk factors such as tobacco and alcohol use, infections, obesity, and physical inactivity.

What are the primary strategic shifts recommended by the WHO report?

The WHO report outlines three strategic shifts focused on better capabilities through universal health coverage, better protections centered on people with lived experience, and better value by aligning research with public health needs.